To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization
Clinical trial NCT06478719 · RECRUITING
Trial details
- NCT number
- NCT06478719
- Sponsor
- Febico Biomedical Corp.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2028-06-07
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.